"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 3 | 0 | 3 |
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 2 | 2 | 4 |
| 2019 | 0 | 2 | 2 |
| 2020 | 3 | 5 | 8 |
| 2021 | 3 | 3 | 6 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease. Mol Neurodegener. 2023 07 04; 18(1):44.
-
Phylogroup-specific variation shapes the clustering of antimicrobial resistance genes and defence systems across regions of genome plasticity in Pseudomonas aeruginosa. EBioMedicine. 2023 Apr; 90:104532.
-
Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC. Gut. 2023 04; 72(4):671-685.
-
External validation of WGS-based antimicrobial susceptibility prediction tools, KOVER-AMR and ResFinder 4.1, for Escherichia coli clinical isolates. Clin Microbiol Infect. 2022 Nov; 28(11):1465-1470.
-
Gene sharing among plasmids and chromosomes reveals barriers for antibiotic resistance gene transfer. Philos Trans R Soc Lond B Biol Sci. 2022 01 17; 377(1842):20200467.
-
Antimicrobial Peptides-or How Our Ancestors Learned to Control the Microbiome. mBio. 2021 10 26; 12(5):e0184721.
-
Recurrent Urinary Tract Infections: Unraveling the Complicated Environment of Uncomplicated rUTIs. Front Cell Infect Microbiol. 2021; 11:562525.
-
Surface Minimal Bactericidal Concentration: A comparative study of active glasses functionalized with different-sized silver nanoparticles. Colloids Surf B Biointerfaces. 2021 Aug; 204:111800.
-
Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with ?-Lactam Antimicrobials. mBio. 2021 03 30; 12(2).
-
Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014-17). J Antimicrob Chemother. 2021 03 12; 76(4):901-908.
MeSH information
